US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist
  • 202.000
  • -2.070-1.01%
Trading Aug 9 10:23 ET
29.42BMarket Cap25.47P/E (TTM)

Biogen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
28.50%625.8M
21.50%553.2M
11.77%1.55B
107.14%12.5M
-10.38%592.4M
-33.88%487M
181.40%455.3M
-61.97%1.38B
-120.88%-175M
-17.92%661M
Net income from continuing operations
-1.63%583.6M
1.50%393.4M
-60.78%1.16B
-54.70%248.9M
-106.02%-68.3M
-43.96%593.3M
77.39%387.6M
71.43%2.96B
2,780.49%549.5M
256.89%1.13B
Operating gains losses
45.21%-58.3M
-60.68%31.3M
115.87%277.1M
-98.67%1.4M
149.37%302.5M
92.58%-106.4M
-59.05%79.6M
-320.46%-1.75B
7.10%105.6M
-243.89%-612.7M
Depreciation and amortization
35.35%158.9M
31.34%147.5M
-4.55%494.8M
16.94%140.1M
3.56%125M
-12.91%117.4M
-21.52%112.3M
6.29%518.4M
-11.06%119.8M
-9.38%120.7M
Deferred tax
18.23%-87M
161.86%39.9M
-81.38%-305.8M
349.65%71.9M
-124.05%-206.8M
-119.38%-106.4M
-6,550.00%-64.5M
60.50%-168.6M
-108.91%-28.8M
27.49%-92.3M
Other non cash items
202.27%146.6M
98.77%97M
-9.31%304.1M
219.10%143.4M
28.08%63.4M
-45.20%48.5M
-84.64%48.8M
-0.53%335.3M
-172.01%-120.4M
-32.19%49.5M
Change In working capital
-44.08%-188.6M
-24.23%-228.7M
27.14%-648.7M
34.37%-648.1M
11,744.44%314.4M
-114.87%-130.9M
76.41%-184.1M
-511.89%-890.3M
-1,395.93%-987.5M
97.68%-2.7M
-Change in receivables
12.54%-87.2M
-26.48%84.4M
125.49%56.7M
218.38%130.1M
-309.72%-88.5M
-279.09%-99.7M
277.71%114.8M
-168.22%-222.4M
-171.04%-109.9M
31.43%-21.6M
-Change in inventory
-18.82%-110.5M
-378.49%-77.7M
59.12%-130.9M
-630.39%-96M
131.79%30.2M
7.65%-93M
119.57%27.9M
30.75%-320.2M
112.95%18.1M
26.24%-95M
-Change in payables and accrued expense
-63.37%61.5M
39.97%-177.1M
-77.78%-201.6M
33.55%-495.5M
24,864.71%421M
-84.68%167.9M
36.09%-295M
-18.87%-113.4M
-604.19%-745.7M
96.90%-1.7M
-Change in other working capital
50.61%-52.4M
-83.33%-58.3M
-59.15%-372.9M
-24.47%-186.7M
-141.78%-48.3M
-20.29%-106.1M
71.53%-31.8M
-371.49%-234.3M
-73.21%-150M
17.12%115.6M
Cash from discontinued investing activities
Operating cash flow
28.50%625.8M
21.50%553.2M
11.77%1.55B
107.14%12.5M
-10.38%592.4M
-33.88%487M
181.40%455.3M
-61.97%1.38B
-120.88%-175M
-17.92%661M
Investing cash flow
Cash flow from continuing investing activities
161.91%466.5M
93.07%-66M
-360.12%-4.1B
-362.30%-652.3M
-204.19%-1.74B
-208.65%-753.5M
-47.07%-953M
379.69%1.58B
-25.20%-141.1M
815.84%1.67B
Net PPE purchase and sale
52.82%-33.5M
31.08%-45.9M
-180.92%-277M
24.54%-65.2M
-114.17%-74.2M
-92.41%-71M
-15.03%-66.6M
232.62%342.3M
-67.44%-86.4M
1,346.43%523.5M
Net intangibles purchase and sale
686.88%93.9M
-1,400.00%-75M
-1,086.21%-34.4M
--0
---13.4M
-742.11%-16M
---5M
92.12%-2.9M
94.08%-1M
--0
Net business purchase and sale
----
----
-719.81%-6.14B
---590.5M
---6.34B
----
----
3,424.20%990.3M
--0
--0
Net investment purchase and sale
100.13%1.9M
106.31%55.6M
960.54%2.36B
117.56%13.4M
307.45%4.68B
-458.88%-1.45B
-49.30%-880.7M
171.82%222.5M
-35.04%-76.3M
774.63%1.15B
Net other investing changes
-550.00%-2.6M
0.00%-700K
-146.31%-11.3M
-144.25%-10M
0.00%-200K
-118.18%-400K
-250.00%-700K
89.15%24.4M
83.74%22.6M
85.71%-200K
Cash from discontinued investing activities
Investing cash flow
161.91%466.5M
93.07%-66M
-360.12%-4.1B
-362.30%-652.3M
-204.19%-1.74B
-208.65%-753.5M
-47.07%-953M
379.69%1.58B
-25.20%-141.1M
815.84%1.67B
Financing cash flow
Cash flow from continuing financing activities
-2,402.04%-245.2M
-912.90%-439.6M
108.54%149.3M
-8,631.08%-646.1M
167.78%848.6M
97.92%-9.8M
-163.03%-43.4M
16.24%-1.75B
-175.51%-7.4M
-67.70%-1.25B
Net issuance payments of debt
---250M
---400M
118.69%187.3M
---650M
--837.3M
--0
--0
-489.53%-1B
--0
----
Net common stock issuance
----
----
--0
--0
----
----
----
58.33%-750M
--0
66.67%-250M
Proceeds from stock option exercised by employees
10.91%6.1M
21.96%-46.9M
-2,231.58%-44.3M
-5.13%3.7M
15.79%6.6M
-40.86%5.5M
-188.94%-60.1M
-171.43%-1.9M
-48.68%3.9M
-3.39%5.7M
Net other financing activities
91.50%-1.3M
-56.29%7.3M
-7.35%6.3M
101.77%200K
187.04%4.7M
-179.69%-15.3M
288.37%16.7M
105.89%6.8M
-613.64%-11.3M
-125.00%-5.4M
Cash from discontinued financing activities
Financing cash flow
-2,402.04%-245.2M
-912.90%-439.6M
108.54%149.3M
-8,631.08%-646.1M
167.78%848.6M
97.92%-9.8M
-163.03%-43.4M
16.24%-1.75B
-175.51%-7.4M
-67.70%-1.25B
Net cash flow
Beginning cash position
-62.93%1.07B
-69.29%1.05B
51.20%3.42B
-37.75%2.29B
-1.09%2.62B
65.68%2.9B
51.20%3.42B
69.88%2.26B
138.40%3.68B
51.93%2.65B
Current changes in cash
406.59%847.1M
108.80%47.6M
-298.13%-2.4B
-297.50%-1.29B
-127.86%-301.2M
-128.83%-276.3M
-7.64%-541.1M
22.59%1.21B
-143.99%-323.5M
718.59%1.08B
Effect of exchange rate changes
-207.32%-12.6M
-215.50%-23.1M
163.02%35.1M
-28.72%47.9M
45.12%-28.7M
93.30%-4.1M
312.77%20M
6.86%-55.7M
525.32%67.2M
-105.91%-52.3M
End cash Position
-27.08%1.91B
-62.93%1.07B
-69.29%1.05B
-69.29%1.05B
-37.75%2.29B
-1.09%2.62B
65.68%2.9B
51.20%3.42B
51.20%3.42B
138.40%3.68B
Free cash flow
45.80%583.2M
12.67%432.3M
8.30%1.24B
79.92%-52.7M
-16.13%504.8M
-42.67%400M
269.30%383.7M
-65.89%1.14B
-134.09%-262.4M
-19.03%601.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 28.50%625.8M21.50%553.2M11.77%1.55B107.14%12.5M-10.38%592.4M-33.88%487M181.40%455.3M-61.97%1.38B-120.88%-175M-17.92%661M
Net income from continuing operations -1.63%583.6M1.50%393.4M-60.78%1.16B-54.70%248.9M-106.02%-68.3M-43.96%593.3M77.39%387.6M71.43%2.96B2,780.49%549.5M256.89%1.13B
Operating gains losses 45.21%-58.3M-60.68%31.3M115.87%277.1M-98.67%1.4M149.37%302.5M92.58%-106.4M-59.05%79.6M-320.46%-1.75B7.10%105.6M-243.89%-612.7M
Depreciation and amortization 35.35%158.9M31.34%147.5M-4.55%494.8M16.94%140.1M3.56%125M-12.91%117.4M-21.52%112.3M6.29%518.4M-11.06%119.8M-9.38%120.7M
Deferred tax 18.23%-87M161.86%39.9M-81.38%-305.8M349.65%71.9M-124.05%-206.8M-119.38%-106.4M-6,550.00%-64.5M60.50%-168.6M-108.91%-28.8M27.49%-92.3M
Other non cash items 202.27%146.6M98.77%97M-9.31%304.1M219.10%143.4M28.08%63.4M-45.20%48.5M-84.64%48.8M-0.53%335.3M-172.01%-120.4M-32.19%49.5M
Change In working capital -44.08%-188.6M-24.23%-228.7M27.14%-648.7M34.37%-648.1M11,744.44%314.4M-114.87%-130.9M76.41%-184.1M-511.89%-890.3M-1,395.93%-987.5M97.68%-2.7M
-Change in receivables 12.54%-87.2M-26.48%84.4M125.49%56.7M218.38%130.1M-309.72%-88.5M-279.09%-99.7M277.71%114.8M-168.22%-222.4M-171.04%-109.9M31.43%-21.6M
-Change in inventory -18.82%-110.5M-378.49%-77.7M59.12%-130.9M-630.39%-96M131.79%30.2M7.65%-93M119.57%27.9M30.75%-320.2M112.95%18.1M26.24%-95M
-Change in payables and accrued expense -63.37%61.5M39.97%-177.1M-77.78%-201.6M33.55%-495.5M24,864.71%421M-84.68%167.9M36.09%-295M-18.87%-113.4M-604.19%-745.7M96.90%-1.7M
-Change in other working capital 50.61%-52.4M-83.33%-58.3M-59.15%-372.9M-24.47%-186.7M-141.78%-48.3M-20.29%-106.1M71.53%-31.8M-371.49%-234.3M-73.21%-150M17.12%115.6M
Cash from discontinued investing activities
Operating cash flow 28.50%625.8M21.50%553.2M11.77%1.55B107.14%12.5M-10.38%592.4M-33.88%487M181.40%455.3M-61.97%1.38B-120.88%-175M-17.92%661M
Investing cash flow
Cash flow from continuing investing activities 161.91%466.5M93.07%-66M-360.12%-4.1B-362.30%-652.3M-204.19%-1.74B-208.65%-753.5M-47.07%-953M379.69%1.58B-25.20%-141.1M815.84%1.67B
Net PPE purchase and sale 52.82%-33.5M31.08%-45.9M-180.92%-277M24.54%-65.2M-114.17%-74.2M-92.41%-71M-15.03%-66.6M232.62%342.3M-67.44%-86.4M1,346.43%523.5M
Net intangibles purchase and sale 686.88%93.9M-1,400.00%-75M-1,086.21%-34.4M--0---13.4M-742.11%-16M---5M92.12%-2.9M94.08%-1M--0
Net business purchase and sale ---------719.81%-6.14B---590.5M---6.34B--------3,424.20%990.3M--0--0
Net investment purchase and sale 100.13%1.9M106.31%55.6M960.54%2.36B117.56%13.4M307.45%4.68B-458.88%-1.45B-49.30%-880.7M171.82%222.5M-35.04%-76.3M774.63%1.15B
Net other investing changes -550.00%-2.6M0.00%-700K-146.31%-11.3M-144.25%-10M0.00%-200K-118.18%-400K-250.00%-700K89.15%24.4M83.74%22.6M85.71%-200K
Cash from discontinued investing activities
Investing cash flow 161.91%466.5M93.07%-66M-360.12%-4.1B-362.30%-652.3M-204.19%-1.74B-208.65%-753.5M-47.07%-953M379.69%1.58B-25.20%-141.1M815.84%1.67B
Financing cash flow
Cash flow from continuing financing activities -2,402.04%-245.2M-912.90%-439.6M108.54%149.3M-8,631.08%-646.1M167.78%848.6M97.92%-9.8M-163.03%-43.4M16.24%-1.75B-175.51%-7.4M-67.70%-1.25B
Net issuance payments of debt ---250M---400M118.69%187.3M---650M--837.3M--0--0-489.53%-1B--0----
Net common stock issuance ----------0--0------------58.33%-750M--066.67%-250M
Proceeds from stock option exercised by employees 10.91%6.1M21.96%-46.9M-2,231.58%-44.3M-5.13%3.7M15.79%6.6M-40.86%5.5M-188.94%-60.1M-171.43%-1.9M-48.68%3.9M-3.39%5.7M
Net other financing activities 91.50%-1.3M-56.29%7.3M-7.35%6.3M101.77%200K187.04%4.7M-179.69%-15.3M288.37%16.7M105.89%6.8M-613.64%-11.3M-125.00%-5.4M
Cash from discontinued financing activities
Financing cash flow -2,402.04%-245.2M-912.90%-439.6M108.54%149.3M-8,631.08%-646.1M167.78%848.6M97.92%-9.8M-163.03%-43.4M16.24%-1.75B-175.51%-7.4M-67.70%-1.25B
Net cash flow
Beginning cash position -62.93%1.07B-69.29%1.05B51.20%3.42B-37.75%2.29B-1.09%2.62B65.68%2.9B51.20%3.42B69.88%2.26B138.40%3.68B51.93%2.65B
Current changes in cash 406.59%847.1M108.80%47.6M-298.13%-2.4B-297.50%-1.29B-127.86%-301.2M-128.83%-276.3M-7.64%-541.1M22.59%1.21B-143.99%-323.5M718.59%1.08B
Effect of exchange rate changes -207.32%-12.6M-215.50%-23.1M163.02%35.1M-28.72%47.9M45.12%-28.7M93.30%-4.1M312.77%20M6.86%-55.7M525.32%67.2M-105.91%-52.3M
End cash Position -27.08%1.91B-62.93%1.07B-69.29%1.05B-69.29%1.05B-37.75%2.29B-1.09%2.62B65.68%2.9B51.20%3.42B51.20%3.42B138.40%3.68B
Free cash flow 45.80%583.2M12.67%432.3M8.30%1.24B79.92%-52.7M-16.13%504.8M-42.67%400M269.30%383.7M-65.89%1.14B-134.09%-262.4M-19.03%601.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Cancer Research
Cancer Research
Intraday-0.22%